M.V.I. 12 660 UNIT
VITAMIN A : 660 UNIT ASCORBIC ACID : 20 MG FOLIC ACID : 0.08 MG VITAMIN B1 (THIAMINE HYDROCHLORIDE) : 0.6 MG D-PANTOTHENIC ACID (PANTHENOL) : 3 MG NICOTINAMIDE : 8 MG VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) : 0.72 MG VITAMIN B12 : 1 MCG BIOTIN : 12 MCG VITAMIN D : 40 UNIT PYRIDOXINE HYDROCHLORIDE : 0.8 MG VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) : 2 UNIT · DIN 01927841 · AVENTIS PHARMA INC
Health Canada status: CANCELLED POST MARKET
What is M.V.I. 12?
M.V.I. 12 660 UNIT contains VITAMIN A : 660 UNIT ASCORBIC ACID : 20 MG FOLIC ACID : 0.08 MG VITAMIN B1 (THIAMINE HYDROCHLORIDE) : 0.6 MG D-PANTOTHENIC ACID (PANTHENOL) : 3 MG NICOTINAMIDE : 8 MG VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) : 0.72 MG VITAMIN B12 : 1 MCG BIOTIN : 12 MCG VITAMIN D : 40 UNIT PYRIDOXINE HYDROCHLORIDE : 0.8 MG VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) : 2 UNIT. It is listed in the Health Canada Drug Product Database under DIN 01927841, held by AVENTIS PHARMA INC, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 29-Jul-2002. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is M.V.I. 12 called?
The same molecule, VITAMINS, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| FruitiVits | Latin | Australia |
| Paediatric Seravit | Latin | Australia |
| Phlexy-Vits | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 01927841 |
|---|---|
| Brand name | M.V.I. 12 |
| Generic / active ingredient | VITAMIN A : 660 UNIT ASCORBIC ACID : 20 MG FOLIC ACID : 0.08 MG VITAMIN B1 (THIAMINE HYDROCHLORIDE) : 0.6 MG D-PANTOTHENIC ACID (PANTHENOL) : 3 MG NICOTINAMIDE : 8 MG VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) : 0.72 MG VITAMIN B12 : 1 MCG BIOTIN : 12 MCG VITAMIN D : 40 UNIT PYRIDOXINE HYDROCHLORIDE : 0.8 MG VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) : 2 UNIT |
| Manufacturer | AVENTIS PHARMA INC |
| Strength | 660 UNIT |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05XC VITAMINS |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 29-Jul-2002 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 01927841 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1927841 |
| Brand name | M.V.I. 12 |
| Active ingredient / INN | VITAMIN A : 660 UNIT ASCORBIC ACID : 20 MG FOLIC ACID : 0.08 MG VITAMIN B1 (THIAMINE HYDROCHLORIDE) : 0.6 MG D-PANTOTHENIC ACID (PANTHENOL) : 3 MG NICOTINAMIDE : 8 MG VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) : 0.72 MG VITAMIN B12 : 1 MCG BIOTIN : 12 MCG VITAMIN D : 40 UNIT PYRIDOXINE HYDROCHLORIDE : 0.8 MG VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) : 2 UNIT |
| ATC code | B05XC |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B05 |
| Health Canada schedule | Ethical |
| Biosimilar biologic | No |
| Market authorization holder | AVENTIS PHARMA INC |
Which pack is which?
| Strength on the label | 660 UNIT |
|---|---|
| Dosage form | LIQUID |
| Route | INTRAVENOUS |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code B05XC VITAMINS. 2 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MULTI 1000 | 1.2 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 00586315 |
| MULTI 12 INJECTION | 0.72 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02100606 |
| M.V.I. PAEDIATRIC | 1.2 MG | LIQUID | AVENTIS PHARMA INC | CANCELLED POST MARKET | DIN 01927833 |
| MEGA-C-SODIUM INJ 250MG/ML | 250 MG | SOLUTION | KRIPPS PHARMACY LTD. | DORMANT | DIN 00525189 |
| MULTI-11 | 8 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02244696 |
| MULTI-12 PEDIATRIC | 1 MCG | LIQUID | SABEX INC | CANCELLED POST MARKET | DIN 02236829 |
| MULTI-VITAMINS FOR INFUSION LIQ | 200 UNIT / 10 ML | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 01904191 |
| MVC 9 PLUS 3 INJ | 15 MG / 5 ML | LIQUID | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | CANCELLED POST MARKET | DIN 01945637 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.